Aristotle University Of Thessaloniki (AUTH)
ΣΥΜΒΟΛΗ ΣΤΗΝ ΕΚΤΙΜΗΣΗ ΤΗΣ ΑΠΟΤΕΛΕΣΜΑΤΙΚΟΤΗΤΑΣ ΤΗΣ ΧΗΜΕΙΟΘΕΡΑΠΕΙΑΣ ΜΕ ΚΥΤΤΑΡΟΓΕΝΕΤΙΚΕΣ ΚΑΙ ΒΙΟΧΗΜΙΚΕΣ ΜΕΘΟΔΟΥΣ
Abstract
dc:descriptionWE OBSERVED DIFFERENTIAL GONOTOXICITY AND ANTITUMOR EFFECT BY CYCLOPHOSPHAMIDE (CP) PLUS 3 - AMINOBENZAMIDE (3 - 4B). ALSO DIFFERENTIAL AMOUNT OF CYTOGENETICDAMAGE WAS OBSERVED WHEN SCES AND PRIS (PROLIFERATION RATE INDEX) WERE EVALUATED IN TWO GROUPS OF PATIENTS SUFFERING FROM BREAST CANCER AND TREATED WITHTWO DIFFERENT SCHEMES (CMF* AND FEC**). FEC WAS PROVED MORE EFFICIENT IN INDUCING IN VIVO SCES AND REDUCED PRIS COMPARED WITH CMF. FROM THE PRESENT STUDYAPPEARS THAT THE ORDER OF ANTITUMOR EFFECTIVENESS OF THE COMBINED CP PLUS 3 -4B TREATMENT AMONG THE EXPERIMENTAL TUMORS TESTED CONSIDES WITH THE ORDER OFCYTOGENETIC EFFECTS IT INDUCED. THEREFORE FROM THE PRESENT FINDINGS SCES APPEAR TO HAVE AN APPLICATION IN THE PREDICTION OF TUMOR SENSITIVITY TO POTENTIAL CHEMOTHERAPEUTICS. *CMF: C: CYCLOPHOSPHAMIDE, M: METHOTREXATE, F: 5 - FLUORACIL, **FEC: F: 5 - FLUORACIL, E: EPIRUBICIN, C: CYCLOPHOSPHAMIDE.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 1995
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Ηλιόπουλος, Παναγιώτης
Subjects
dc:subject × 20- ΑΝΤΙΝΕΟΠΛΑΣΜΑΤΙΚΑ ΧΗΜΕΙΟΘΕΡΑΠΕΥΤΙΚΑ ΜΕΣΑ
- ΔΟΚΙΜΑΣΙΑ AMES
- Μηχανισμοί επιδιόρθωσης DNA
- Μικροπυρήνες
- ΠΕΙΡΑΜΑΤΙΚΟΙ ΜΕΤΑΜΟΣΧΕΥΣΙΜΟΙ ΟΓΚΟΙ
- Χρωματιδιακές ανταλλαγές
- Ames test
- CANCER DRUG DEVELOPMENT
- DNA repair mechanisms
- EAT
- Experimental transplantable tumor
- L 1210
- Micronuclei
- P 388
- S.C.E.S
- SISTER CHROMATID EXCHANGE
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/8985